SYSTOLIC-TIME INTERVALS DURING SPIRONOLACTONE TREATMENT OF DIGITALIZED AND NON-DIGITALIZED PATIENTS WITH ISCHEMIC-HEART-DISEASE

被引：7

作者：

WALDORFF, S ^{[1
]}

BERNING, J ^{[1
]}

BUCH, J ^{[1
]}

STEINESS, E ^{[1
]}

机构：

[1] UNIV COPENHAGEN,DEPT PHARMACOL,COPENHAGEN,DENMARK

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1982年 / 21卷 / 04期

关键词：

D O I：

10.1007/BF00637612

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：269 / 273

页数：5

共 22 条

[1]

BASKIN SI, 1973, P SOC EXP BIOL MED, V143, P495

[2]

BEVEGARD S, 1977, ACTA MED SCAND, V202, P373

[3]

BUCH J, 1980, BRIT HEART J, V44, P668

[4]

CORABOEUF E, 1974, J PHARMACOL EXP THER, V191, P128

[5] ELECTROPHYSIOLOGIC EFFECTS OF POTASSIUM CANRENOATE ON OUABAIN-INDUCED VENTRICULAR DYSRHYTHMIAS IN RABBITS [J].

CSAPO, G ;

SOHN, YJ ;

YEH, BK .

PHARMACOLOGY, 1974, 11 (06) :336-345

[6] LACK OF INTERACTION OF SPIRONOLACTONE WITH OUABAIN IN GUINEA-PIG ISOLATED HEART-MUSCLE PREPARATIONS [J].

FRICKE, U .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 49 (04) :363-371

[7] NOMOGRAM FOR DIGOXIN THERAPY [J].

JELLIFFE, RW ;

BROOKER, G .

AMERICAN JOURNAL OF MEDICINE, 1974, 57 (01) :63-68

[8]

KARIM A, 1976, CLIN PHARMACOL THER, V19, P158

[9]

KOTTER V, 1977, Z KARDIOL, V64, P672

[10]

MUSGRAVE GE, 1977, J PHARMACOL EXP THER, V202, P696

← 1 2 3 →